Inherently Stealthy and Highly Tumor-Selective Gold Nanoraspberries for Photothermal Cancer Therapy

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Gandra, Naveen ^a,b   Portz, Christopher ^a   Nergiz, Saide Z ^a   Fales, Andrew ^b   Vo Dinh, Tuan ^b   Singamaneni, Srikanth ^a  

^a WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^b Duke University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; DRUG CARRIER; GOLD; METAL NANOPARTICLE;

BREAST NEOPLASMS; CHEMISTRY; COCULTURE; FEMALE; HUMAN; PHOTOTHERAPY; PROCEDURES; SURFACE PLASMON RESONANCE; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHITOSAN; COCULTURE TECHNIQUES; DRUG CARRIERS; FEMALE; GOLD; HUMANS; METAL NANOPARTICLES; PHOTOTHERAPY; SURFACE PLASMON RESONANCE;

EID: 84929340323     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10311     Document Type: Article

References (32)

1. Larson, T. A., Joshi, P. P. & Sokolov, K. Preventing Protein Adsorption and Macrophage Uptake of Gold Nanoparticles via a Hydrophobic Shield. ACS Nano 6, 9182-9190, doi:10.1021/nn3035155 (2012).
2. Cheng, Y. et al. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J. Am. Chem. Soc. 130, 10643-10647, doi:10.1021/ja801631c (2008).
3. Gibson, J. D., Khanal, B. P. & Zubarev, E. R. Paclitaxel-functionalized gold nanoparticles. J. Am. Chem. Soc. 129, 11653-11661, doi:10.1021/ja075181k (2007).
4. Huang, X. H., Jain, P. K., El-Sayed, I. H. & El-Sayed, M. A. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Laser. Med. Sci. 23, 217-228, doi:10.1007/s10103-007-0470-x (2008).
5. Kim, D., Jeong, Y. Y. & Jon, S. A Drug-Loaded Aptamer-Gold Nanoparticle Bioconjugate for Combined CT Imaging and Therapy of Prostate Cancer. ACS Nano 4, 3689-3696, doi:10.1021/nn901877h (2010).
6. Mallidi, S. et al. Multiwavelength Photoacoustic Imaging and Plasmon Resonance Coupling of Gold Nanoparticles for Selective Detection of Cancer. Nano Lett. 9, 2825-2831, doi:10.1021/nl802929u (2009).
7. Popovtzer, R. et al. Targeted Gold Nanoparticles Enable Molecular CT Imaging of Cancer. Nano Lett. 8, 4593-4596, doi:10.1021/nl8029114 (2008).
8. Portney, N. G. & Ozkan, M. Nano-oncology: drug delivery, imaging, and sensing. Anal. Bioanal. Chem. 384, 620-630, doi:10.1007/s00216-005-0247-7 (2006).
9. Visaria, R. K. et al. Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery. Mol. Cancer Ther. 5, 1014-1020, doi:10.1158/1535-7163.mct-05-0381 (2006).
10. Hirsch, L. R. et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. PNAS 100, 13549-13554, doi:10.1073/pnas.2232479100 (2003).
11. Jain, P. K., El-Sayed, I. H. & El-Sayed, M. A. Au nanoparticles target cancer. Nano Today 2, 18-29, doi:10.1016/s1748-0132(07)70016-6 (2007).
12. Gandra, N., Portz, C. & Singamaneni, S. Multifunctional Plasmonic Nanorattles for Spectrum-Guided Locoregional Therapy. Adv. Mater. 26, 424-429, doi:10.1002/adma.201302803 (2013).
13. Gandra, N. & Singamaneni, S. Bilayered Raman-Intense Gold Nanostructures with Hidden Tags (BRIGHTs) for High-Resolution Bioimaging. Adv. Mater. 25, 1022-1027, doi:10.1002/adma.201203415 (2013).
14. Gao, W. et al. Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes. Adv. Mater. 25, 3549-3553, doi:10.1002/adma.201300638 (2013).
15. Rodriguez, P. L. et al. Minimal "Self " Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles. Science 339, 971-975, doi:10.1126/science.1229568 (2013).
16. Mross, K. et al. Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study. Cancer Chemother. Pharmacol. 54, 514-524, doi:10.1007/s00280-004-0825-y (2004).
17. Weiss, R. B. The Anthracyclines - Will We Ever Find a Better Doxrubicin. Seminars in Oncology 19, 670-686 (1992).
18. Cho, K. J., Wang, X., Nie, S. M., Chen, Z. & Shin, D. M. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 14, 1310-1316, doi:10.1158/1078-0432.ccr-07-1441 (2008).
19. Maeda, H., Wu, J., Sawa, T., Matsumura, Y. & Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65, 271-284, doi:10.1016/s0168-3659(99)00248-5 (2000).
20. Maeda, H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Advances in Enzyme Regulation 41, 189-207, doi:http://dx.doi.org/10.1016/S0065-2571(00)00013-3 (2001).
21. Veronese, F. M. & Pasut, G. PEGylation, successful approach to drug delivery. Drug Discovery Today 10, 1451-1458, doi:10.1016/s1359-6446(05)03575-0 (2005).
22. Hong, R.-L. et al. Direct Comparison of Liposomal Doxorubicin with or without Polyethylene Glycol Coating in C-26 Tumor-bearing Mice: Is Surface Coating with Polyethylene Glycol Beneficial? Clin. Cancer Res. 5, 3645-3652 (1999).
23. Berenson, A. A cancer drug shows promise, at a price that many can't pay. New York Times 15, 2618-2622 (2006).
24. Fleck, L. M. The costs of caring: Who pays? Who profits? Who panders? Hastings Center Report 36, 13-17 (2006).
25. Cheng, Z., Al Zaki, A., Hui, J. Z., Muzykantov, V. R. & Tsourkas, A. Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities. Science 338, 903-910, doi:10.1126/science.1226338 (2012).
26. Nel, A. E. et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 8, 543-557 (2009).
27. Yang, R. et al. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor. Int. J. Pharm. 371, 142-147, doi:http://dx.doi.org/10.1016/j.ijpharm.2008.12.007 (2009).
28. Liu, X. et al. Enhanced Retention and Cellular Uptake of Nanoparticles in Tumors by Controlling Their Aggregation Behavior. ACS Nano 7, 6244-6257, doi:10.1021/nn402201w (2013).
29. Chourasia, M. K. & Jain, S. K. Polysaccharides for Colon Targeted Drug Delivery. Drug Delivery 11, 129-148, doi:10.1080/10717540490280778 (2004).
30. Chen, H., Ahn, R., Van den Bossche, J., Thompson, D. H. & O'Halloran, T. V. Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide. Mol. Cancer Ther. 8, 1955-1963, doi:10.1158/1535-7163.MCT-09-0045 (2009).
31. Chen, F. et al. Engineering of Hollow Mesoporous Silica Nanoparticles for Remarkably Enhanced Tumor Active Targeting Efficacy. Sci. Rep. 4, doi:10.1038/srep05080 http://www.nature.com/srep/2014/140530/srep05080/abs/srep05080.html (2014).
32. Tonga, G. Y., Saha, K. & Rotello, V. M. 25th Anniversary Article: Interfacing Nanoparticles and Biology: New Strategies for Biomedicine. Adv. Mater. 26, 359-370, doi:10.1002/adma.201303001 (2014).